![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Neuren and Metabolic to Develop Nerve Repair Compounds
Neuren and Metabolic to Develop Nerve Repair Compounds
Neuren Pharmaceuticals and Metabolic Pharmaceuticals have agreed to collaborate to co-develop a class of nerve repair compounds for the treatment of degenerative conditions such as peripheral neuropathy, motor neuron disease and repairing the brain or nerves after injuries. Neuren Pharmaceuticals and Metabolic Pharmaceuticals will jointly develop Neuren's class of neuro-regenerative peptides (NRPs) with all intellectual property and commercial outcomes to be equally shared.
Yahoo News (http://uk.biz.yahoo.com/050307/241/fdve2.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
18Jul
-
21Oct